Accueil・Liste d'Actions・PerkinElmer Inc

PerkinElmer Inc

Fermé

SecteurSoins de santé

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés
By Trading Economics
Revenu	-58M 41M
Ventes	-61M 711M
P/E Moyenne du Secteur	55.394 68.51
BPA	1.06
Rendement du dividende	0.25
Marge bénéficiaire	5.726
Employés	11,000
EBITDA	-38M 180M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+0.79% upside

Dividendes
By Acuity
Rendement du dividende Moyenne du Secteur	0.25% 2.29%
Prochains Résultats	26 oct. 2026
Date du Prochain Détachement de Dividende	23 oct. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	3.2B 13B
Ouverture précédente	0
Clôture précédente	0

Sentiment de l'Actualité

By Acuity

29%

71%

73 / 340 Classement par Healthcare

PerkinElmer Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 août 2026, 19:46 UTC

Revvity Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

6 août 2026, 20:51 UTC

Revvity Inc shares are lower in after-market hours, with no specific news identified. The asset remains above its 20-day moving average.

5 août 2026, 19:52 UTC

News

Revvity Inc shares are higher as Evercore ISI raises its price target to $126, supported by strong quarterly performance and increased guidance.

4 août 2026, 19:51 UTC

Social Media

News

Revvity Inc shares are lower following second-quarter results that showed organic revenue growth of 3% and a slight miss on overall revenue estimates.

3 août 2026, 19:44 UTC

News

Revvity Inc shares are higher ahead of tomorrow's earnings report, with analysts projecting a 3.9% revenue growth year-on-year, recovering from last year's decline.

31 juil. 2026, 19:16 UTC

Revvity Inc shares are lower today amid broader market declines, influenced by rising yields and inflation concerns following a significant increase in crude oil prices.

29 juil. 2026, 20:08 UTC

Revvity Inc shares are higher today, reflecting a steady upward trend amid rising oil prices and broader market influences. The stock is near its one-month range high.

28 juil. 2026, 20:03 UTC

Revvity Inc shares are higher during Tuesday's session, continuing their advance since Monday's close, despite broader market weakness in Asian indices.

27 juil. 2026, 21:02 UTC

Revvity Inc shares are lower in after-market hours, continuing a downward trend with three consecutive daily declines. No specific news was identified for the movement.

22 juil. 2026, 18:51 UTC

Revvity Inc shares are higher since Tuesday's close amid broader market gains, influenced by rising crude oil prices from geopolitical tensions involving the U.S. and Iran.

21 juil. 2026, 20:02 UTC

Revvity Inc shares are higher, supported by renewed interest in AI stocks and anticipation of earnings from major companies like Alphabet and Tesla.

20 juil. 2026, 19:21 UTC

News

Revvity Inc. published its 2026 Impact Report, disclosing Scope 3 emissions. Shares are lower amid broader industry challenges and a cautious analyst outlook.

Comparaison

Variation de prix

PerkinElmer Inc prévision

Objectif de Prix

By TipRanks

0.79% hausse

Prévisions sur 12 Mois

Moyen 115.14 USD 0.79%

Haut 130 USD

Bas 105 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

11 ratings

Achat

Maintien

Vente

Basé sur 11 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

73 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.